Chandrasekhar V, Yelkur P, K V
Cureus. 2024; 16(8):e67291.
PMID: 39301409
PMC: 11412278.
DOI: 10.7759/cureus.67291.
Zhang P, Yang J, Liu X, Huang C, Tao Y, Shen P
Cell Death Dis. 2024; 15(6):392.
PMID: 38834617
PMC: 11150480.
DOI: 10.1038/s41419-024-06706-6.
Dyrstad S, Lotsberg M, Tan T, Pettersen I, Hjellbrekke S, Tusubira D
Cancers (Basel). 2021; 13(5).
PMID: 33668151
PMC: 7956357.
DOI: 10.3390/cancers13050941.
Keywan C, Poduri A, Goldstein R, Holm I
Appl Clin Genet. 2021; 14:61-76.
PMID: 33623412
PMC: 7894824.
DOI: 10.2147/TACG.S239478.
Baruteau J, Khalil Y, Grunewald S, Zancolli M, Chakrapani A, Cleary M
Metabolites. 2019; 9(11).
PMID: 31718089
PMC: 6918381.
DOI: 10.3390/metabo9110275.
Novel fructose bisphosphatase 1 gene mutation presenting as recurrent episodes of vomiting in an Indian child.
Sharma A, Kanwal S, Chhapola V, Kumar V
J Postgrad Med. 2018; 64(3):180-182.
PMID: 29992913
PMC: 6066631.
DOI: 10.4103/jpgm.JPGM_216_17.
Mitochondrial Fatty Acid Oxidation Disorders Associated with Short-Chain Enoyl-CoA Hydratase (ECHS1) Deficiency.
Sharpe A, McKenzie M
Cells. 2018; 7(6).
PMID: 29882869
PMC: 6025059.
DOI: 10.3390/cells7060046.
Arginase 2 Suppresses Renal Carcinoma Progression via Biosynthetic Cofactor Pyridoxal Phosphate Depletion and Increased Polyamine Toxicity.
Ochocki J, Khare S, Hess M, Ackerman D, Qiu B, Daisak J
Cell Metab. 2018; 27(6):1263-1280.e6.
PMID: 29754953
PMC: 5990482.
DOI: 10.1016/j.cmet.2018.04.009.
Targeting FBPase is an emerging novel approach for cancer therapy.
Liu G, Zhang Y
Cancer Cell Int. 2018; 18:36.
PMID: 29556139
PMC: 5845355.
DOI: 10.1186/s12935-018-0533-z.
Down-regulation of FBP1 by ZEB1-mediated repression confers to growth and invasion in lung cancer cells.
Zhang J, Wang J, Xing H, Li Q, Zhao Q, Li J
Mol Cell Biochem. 2015; 411(1-2):331-40.
PMID: 26546081
DOI: 10.1007/s11010-015-2595-8.
Transient pseudo-hypertriglyceridemia: a useful biochemical marker of fructose-1,6-bisphosphatase deficiency.
Afroze B, Yunus Z, Steinmann B, Santer R
Eur J Pediatr. 2013; 172(9):1249-53.
PMID: 23881342
DOI: 10.1007/s00431-013-2084-6.
Loss of FBP1 by Snail-mediated repression provides metabolic advantages in basal-like breast cancer.
Dong C, Yuan T, Wu Y, Wang Y, Fan T, Miriyala S
Cancer Cell. 2013; 23(3):316-31.
PMID: 23453623
PMC: 3703516.
DOI: 10.1016/j.ccr.2013.01.022.
Postmortem computed tomography for detecting causes of sudden death in infants and children: retrospective review of cases.
Oyake Y, Aoki T, Shiotani S, Kohno M, Ohashi N, Akutsu H
Radiat Med. 2006; 24(7):493-502.
PMID: 17058143
DOI: 10.1007/s11604-006-0061-y.
Identification of novel polymorphisms in the glucokinase and glucose-6-phosphatase genes in infants who died suddenly and unexpectedly.
Forsyth L, Hume R, Howatson A, Busuttil A, Burchell A
J Mol Med (Berl). 2005; 83(8):610-8.
PMID: 15918042
DOI: 10.1007/s00109-005-0666-0.
Diagnosis of fructose-1,6-bisphosphatase deficiency using cultured lymphocyte fraction: a secure and noninvasive alternative to liver biopsy.
Kikawa Y, Shin Y, Inuzuka M, Zammarchi E, Mayumi M
J Inherit Metab Dis. 2002; 25(1):41-6.
PMID: 11999979
DOI: 10.1023/a:1015129616599.
Characterization of the human liver fructose-1,6-bisphosphatase gene promoter.
Herzog B, Scott D, Eschrich K, GRANNER D
Biochem J. 2000; 351 Pt 2:385-92.
PMID: 11023824
PMC: 1221374.
Identification of genetic mutations in Japanese patients with fructose-1,6-bisphosphatase deficiency.
Kikawa Y, Inuzuka M, Jin B, Kaji S, Koga J, Yamamoto Y
Am J Hum Genet. 1997; 61(4):852-61.
PMID: 9382095
PMC: 1715983.
DOI: 10.1086/514875.
Sudden infant death and lysinuric protein intolerance.
De Klerk J, Duran M, Huijmans J, Mancini G
Eur J Pediatr. 1996; 155(3):256-7.
PMID: 8929742
DOI: 10.1007/BF01953953.
Abnormal expression of glucose-6-phosphatase in preterm infants.
HUME R, Burchell A
Arch Dis Child. 1993; 68(2):202-4.
PMID: 8386919
PMC: 1029235.
DOI: 10.1136/adc.68.2.202.
Biochemical screening in newborn siblings of cases of SIDS.
Green A
Arch Dis Child. 1993; 68(6):793-6.
PMID: 8333777
PMC: 1029379.
DOI: 10.1136/adc.68.6.793.
